A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the feasibility of Retrovir (AZT) in the treatment of psoriasis in HIV antibody
positive patients. Retrovir has been shown to be effective in the treatment of AIDS. In
addition, the administration of AZT appears to have induced a remission of psoriasis in one
case study. In light of AZT's antiviral activity and potential effectiveness as an agent for
the treatment of psoriasis, this would be the most likely treatment for HIV positive,
psoriatic patients whose disease progresses quickly.